Therapeutic assessment of Nerium oleander-derived exosome-like nanoparticles against triple-negative breast cancer: a preliminary in vitro and network pharmacology approach

• by Sreyoshi Routh, Tomsy Joseph, Arya Sreekumar, Venkatraman Manickam

• July 10, 2026

Concurrent B-cell acute lymphoblastic leukemia and plasma cell neoplasm with plasmablastic features supporting divergent evolution from a shared precursor: a case report

• by Antonija Babić, Ivana Franić Šimić, Josip Knežević, Koraljka Gjadrov Kuveždić, Ivana Ilić, Ida Ivek, Lara Divjak, Alojzija Brčić, Klara Bardač, Dora Višnjić, Radovan Vrhovac, Vilma Dembitz, Drago Batinić, Hrvoje Lalić

• July 10, 2026

Clinical features and treatment challenges of HER2-positive primary breast squamous cell carcinoma: a case report and literature review

• by Fang Yang, Siyu Guo, Ping Li, Mengqi Yang, Xuan Wu

• July 9, 2026

Inside the Rise of circRNA

Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality

• July 9, 2026

• 12 min